Reported positions
Quarter-end holdings as filed
Explore the full published position list and its source filing. This record excludes the manager’s cash, shorts and non-13(f) assets.
Rubric Capital Management LP
A quarter-end snapshot. Filed up to 45 days later, so this page is not current holdings and never a complete portfolio. what a 13F is — and is not ↓ · methodology §13F ↗
Period
$9.4B
reported valuesum of disclosed values for 2026-03-31; 0 positions carry a NULL value and are excluded from the sum, surfaced here rather than folded away
83
positionsALL retained default holdings for this (filer, period), including NULL-value ones
17
new stakespositions with no comparable holding in the prior quarter (kind new), 2026-03-31
10
exitspositions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record
Position changes — into 2026-03-31
by shares · Δ value · filing link · how changes are classified §Positionposition matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match identity_reconciled_by_cusip | Changethe reported share count is unchanged across the pair, so the position reads as held rather than as a buy or a sell; only builds before this release inferred a direction from the reported value instead classified_by_value · "exit" = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · "no change" = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an add or a trim (Add / New / Trim / Exit / No change) · "no prior" = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake | Δ valuederived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero | Δ shares | Prev value | Curr value | Prev shares | Curr shares | Flags |
|---|---|---|---|---|---|---|---|---|
ISHARES TR RUSSELL 2000 ETFposition key pos:16595 · issuer key iss:1231 PUT | new | +$1.3B | +5,150,000 | $0 | $1.3B | — | 5,150,000 | |
FTAI AVIATION LTD SHSposition key pos:16242 · issuer key iss:2512 | trim | −$97.2M | −1,123,814 | $728M | $631M | 3,700,000 | 2,576,186 | |
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADSposition key pos:15751 · issuer key iss:2120 | trim | −$207M | −6,105,510 | $667M | $459M | 21,355,510 | 15,250,000 | |
VIATRIS INC COMposition key pos:16938 · issuer key iss:2270 | add | +$135M | +8,000,000 | $317M | $453M | 25,500,000 | 33,500,000 | |
BGC GROUP INC CL Aposition key pos:13890 · issuer key iss:369 | add | +$40.3M | +2,300,000 | $188M | $228M | 21,000,000 | 23,300,000 | |
VISTRA CORP COMposition key pos:12068 · issuer key iss:2283 | trim | −$97.2M | −500,000 | $323M | $225M | 2,000,000 | 1,500,000 | |
CONSTELLATION ENERGY CORP COMposition key pos:17409 · issuer key iss:648 | add | −$37.0M | +45,000 | $237M | $200M | 670,000 | 715,000 | |
MERCURY GENL CORP NEW COMposition key pos:16900 · issuer key iss:1463 | add | −$3.3M | +100,000 | $193M | $190M | 2,054,504 | 2,154,504 | |
KINIKSA PHARMACEUTICALS INTL ORD SHS CL Aposition key pos:14218 · issuer key iss:2550 | add | +$43.3M | +421,347 | $137M | $181M | 3,328,653 | 3,750,000 | |
ZYMEWORKS INC COMposition key sid:sec:prov:cc436d9af4067ff4382c62284d4ff9e5 · issuer key cusip6:98985Y | add | +$23.9M | +1,250,000 | $151M | $175M | 5,750,000 | 7,000,000 | |
AKAMAI TECHNOLOGIES INC COMposition key pos:17942 · issuer key iss:108 | add | +$44.6M | +100,000 | $105M | $149M | 1,200,000 | 1,300,000 | |
LIBERTY GLOBAL LTD COM CL Aposition key pos:16919 · issuer key iss:2567 | add | +$30.5M | +1,734,423 | $112M | $142M | 10,018,432 | 11,752,855 | |
ROIVANT SCIENCES LTD SHSposition key pos:18572 · issuer key iss:2604 | trim | −$56.8M | −4,000,000 | $195M | $139M | 9,000,000 | 5,000,000 | |
AMNEAL PHARMACEUTICALS INC COM STK CL Aposition key pos:13504 · issuer key iss:195 | trim | −$18.2M | −1,297,352 | $155M | $137M | 12,334,941 | 11,037,589 | |
LIBERTY LATIN AMERICA LTD COM CL Cposition key sid:sec:prov:3b6c450c94b0758fbbc866002762462a · issuer key cusip6:G9001E | add | +$56.3M | +4,738,495 | $79.5M | $136M | 10,656,935 | 15,395,430 | |
CIMPRESS PLC SHS EUROposition key sid:sec:prov:fdf8fd060e542d035c44c1ded6f238c8 · issuer key cusip6:G2143T | add | +$17.4M | +104,419 | $102M | $119M | 1,525,000 | 1,629,419 | |
ECOVYST INC COMposition key pos:14460 · issuer key iss:794 | trim | +$15.3M | −1,363,933 | $102M | $117M | 10,500,000 | 9,136,067 | |
LIBERTY GLOBAL LTD COM CL Cposition key pos:11569 · issuer key iss:2567 | add | +$41.0M | +3,137,779 | $67.6M | $109M | 6,121,582 | 9,259,361 | |
EDGEWELL PERSONAL CARE CO COMposition key sid:sec:prov:b77d43bf1d40816a26209638478fe3b9 · issuer key cusip6:28035Q | add | +$68.2M | +2,992,929 | $17.2M | $85.4M | 1,007,071 | 4,000,000 | |
ZOOM COMMUNICATIONS INC CL Aposition key pos:18866 · issuer key iss:2383 | new | +$80.5M | +1,001,006 | $0 | $80.5M | — | 1,001,006 | |
GILDAN ACTIVEWEAR INC COMposition key pos:13014 · issuer key iss:1009 | add | +$61.7M | +1,139,392 | $16.0M | $77.7M | 256,398 | 1,395,790 | |
SCHRODINGER INC COMposition key pos:14505 · issuer key iss:1937 | add | −$6.4M | +1,828,502 | $74.6M | $68.2M | 4,171,498 | 6,000,000 | |
ARS PHARMACEUTICALS INC COMposition key pos:11241 · issuer key iss:1972 | add | −$8.0M | +1,800,000 | $72.2M | $64.2M | 6,200,000 | 8,000,000 | |
GEO GROUP INC COMposition key pos:13942 · issuer key iss:974 | add | +$6.7M | +256,265 | $56.2M | $62.9M | 3,486,915 | 3,743,180 | |
STRATASYS LTD SHSposition key sid:sec:prov:41722723712204ebe20d97d3e8e3a477 · issuer key cusip6:M85548 | add | −$1.2M | +659,974 | $63.7M | $62.5M | 7,340,026 | 8,000,000 | |
ANDERSONS INC COMposition key pos:11585 · issuer key iss:202 | trim | +$8.0M | −149,812 | $53.5M | $61.4M | 1,005,631 | 855,819 | |
MEIRAGTX HLDGS PLC COMposition key sid:sec:prov:8c4f97ba195668adc97a71db173c878f · issuer key cusip6:G59665 | add | +$11.5M | +824,669 | $49.1M | $60.6M | 6,175,331 | 7,000,000 | |
QUIDELORTHO CORP COMposition key sid:sec:prov:d05419f16e8892a63b605f2d803db063 · issuer key cusip6:219798 | trim | −$53.6M | −470,876 | $108M | $54.3M | 3,777,157 | 3,306,281 | |
PRIMO BRANDS CORPORATION CLASS A COM SHSposition key pos:13576 · issuer key iss:1753 | trim | −$6.9M | −846,411 | $59.3M | $52.4M | 3,628,815 | 2,782,404 | |
NEWELL BRANDS INC COMposition key pos:11360 · issuer key iss:1560 | add | +$4.0M | +2,257,431 | $48.4M | $52.3M | 13,000,000 | 15,257,431 | |
AMCOR PLC COM NEWposition key pos:19102 · issuer key iss:2421 | new | +$50.5M | +1,269,396 | $0 | $50.5M | — | 1,269,396 | |
PROTHENA CORP PLC SHSposition key sid:sec:prov:735c615b8eee997b1e5307c5a30a9301 · issuer key cusip6:G72800 | add | +$13.5M | +1,322,669 | $35.1M | $48.6M | 3,677,331 | 5,000,000 | |
PROTAGONIST THERAPEUTICS INC COMposition key pos:14826 · issuer key iss:1773 | new | +$45.1M | +427,998 | $0 | $45.1M | — | 427,998 | |
TREVI THERAPEUTICS INC COMposition key pos:18739 · issuer key iss:2160 | trim | −$2.9M | −54,376 | $47.2M | $44.3M | 3,766,749 | 3,712,373 | |
COLLEGIUM PHARMACEUTICAL INC COMposition key pos:18501 · issuer key iss:619 | trim | −$27.0M | −216,825 | $69.3M | $42.3M | 1,496,436 | 1,279,611 | |
CORECIVIC INC COMposition key pos:13971 · issuer key iss:654 | add | +$1.5M | +97,770 | $37.5M | $38.9M | 1,961,446 | 2,059,216 | |
DRIVEN BRANDS HLDGS INC COMposition key pos:11049 · issuer key iss:767 | new | +$37.8M | +3,000,000 | $0 | $37.8M | — | 3,000,000 | |
CALAVO GROWERS INC COMposition key sid:sec:prov:9e6b6deb326848fd61ffbad8ed58ed60 · issuer key cusip6:128246 | new | +$36.5M | +1,416,662 | $0 | $36.5M | — | 1,416,662 | |
CARTERS INC COMposition key pos:17872 · issuer key iss:531 | add | +$21.5M | +558,853 | $14.9M | $36.4M | 460,000 | 1,018,853 | |
VISTANCE NETWORKS INC COMposition key pos:16406 · issuer key iss:628 | new | +$36.4M | +2,000,000 | $0 | $36.4M | — | 2,000,000 | |
LIBERTY LATIN AMERICA LTD COM CL Aposition key sid:sec:prov:cd76b1d0504c361157013f558d333f9c · issuer key cusip6:G9001E | add | +$18.0M | +1,806,935 | $14.4M | $32.4M | 1,943,065 | 3,750,000 | |
ARBUTUS BIOPHARMA CORP COMposition key pos:12960 · issuer key iss:231 | add | +$22.2M | +5,051,013 | $7.6M | $29.8M | 1,575,376 | 6,626,389 | |
PROTO LABS INC COMposition key pos:15946 · issuer key iss:1774 | trim | −$29.1M | −636,938 | $56.8M | $27.7M | 1,123,338 | 486,400 | |
COMPASS INC CL Aposition key pos:11540 · issuer key iss:636 | trim | −$46.6M | −3,253,152 | $74.0M | $27.4M | 7,000,000 | 3,746,848 | |
BIOMARIN PHARMACEUTICAL INC COMposition key pos:11882 · issuer key iss:375 | new | +$24.9M | +440,560 | $0 | $24.9M | — | 440,560 | |
MISSION PRODUCE INC COMposition key pos:15555 · issuer key iss:1487 | new | +$23.8M | +1,726,447 | $0 | $23.8M | — | 1,726,447 | |
VENTURE GLOBAL INC COM CL Aposition key pos:13864 · issuer key iss:2253 | new | +$23.6M | +1,500,000 | $0 | $23.6M | — | 1,500,000 | |
INDIVIOR PHARMACEUTICALS INC COMposition key pos:18425 · issuer key iss:1171 | new | +$20.2M | +662,515 | $0 | $20.2M | — | 662,515 | |
ADMA BIOLOGICS INC COMposition key pos:15764 · issuer key iss:10 | new | +$16.3M | +1,809,408 | $0 | $16.3M | — | 1,809,408 | |
DNOW INC COMposition key pos:11092 · issuer key iss:1590 | new | +$15.1M | +1,267,527 | $0 | $15.1M | — | 1,267,527 | |
ARDELYX INC COMposition key pos:16597 · issuer key iss:237 | new | +$11.1M | +1,860,896 | $0 | $11.1M | — | 1,860,896 | |
MANNKIND CORP COM NEWposition key sid:sec:prov:9318e51aacd9a6ead589f2a198b9f099 · issuer key cusip6:56400P | trim | −$33.5M | −3,856,082 | $42.4M | $8.9M | 7,476,495 | 3,620,413 | |
GRUPO AEROMEXICO SAB DE CV SPONSORED ADSposition key sid:sec:prov:3c23807753533cb6de177ae24d74ffc3 · issuer key cusip6:40054J | new | +$6.5M | +467,129 | $0 | $6.5M | — | 467,129 | |
HELEN OF TROY LTD COMposition key sid:sec:prov:e6e20011c37a91a9f94616e000151d55 · issuer key cusip6:G4388N | add | −$179K | +109,289 | $5.5M | $5.3M | 256,937 | 366,226 | |
EUPRAXIA PHARMACEUTICALS INC COMposition key sid:sec:prov:7acc8bc210a65ae94fd3816bb18f4409 · issuer key cusip6:29842P | new | +$5.0M | +691,170 | $0 | $5.0M | — | 691,170 | |
PENNYMAC FINL SVCS INC NEW COMposition key sid:sec:prov:36439369a6f001bd5cef6411613f9e2a · issuer key cusip6:70932M | new | +$4.8M | +54,727 | $0 | $4.8M | — | 54,727 | |
| pos:11452 | exit‡e | −$17.9M | −498,527 | $17.9M | $0 | 498,527 | — | |
| pos:12539 | exit‡e | −$24.5M | −680,827 | $24.5M | $0 | 680,827 | — | |
| pos:12765 | exit‡e | −$15.5M | −400,000 | $15.5M | $0 | 400,000 | — | |
| pos:12851 | exit‡e | −$60.3M | −676,510 | $60.3M | $0 | 676,510 | — | |
| pos:12873 | exit‡e | −$63.3M | −1,101,583 | $63.3M | $0 | 1,101,583 | — | |
| pos:15289 | exit‡e | −$164M | −4,143,808 | $164M | $0 | 4,143,808 | — | |
| pos:16424 | exit‡e | −$30.1M | −2,000,000 | $30.1M | $0 | 2,000,000 | — | |
| pos:17118 | exit‡e | −$10.6M | −784,854 | $10.6M | $0 | 784,854 | — | |
| sid:sec:prov:2c589e410add571ec783f5e19ea71894 | exit‡e | −$74.5M | −6,500,000 | $74.5M | $0 | 6,500,000 | — | |
| sid:sec:prov:31bd096d76f11be58e8f9b95ba95be3f | exit‡e | −$27.0M | −23,701,399 | $27.0M | $0 | 23,701,399 | — |
46 more changes below.
Mark-to-market only (no share change) · 27
Positions whose share count is identical in both quarters; the value changed with price, not with a decision.
Positionposition matched across quarters by exact reported CUSIP over a registry gap — producer-reconciled identity, never a name match identity_reconciled_by_cusip | Changethe reported share count is unchanged across the pair, so the position reads as held rather than as a buy or a sell; only builds before this release inferred a direction from the reported value instead classified_by_value · "exit" = absent this quarter: disposed, delisted, under confidential treatment, or reported instead by an affiliated manager — the filing does not say which · change not classifiable: value undisclosed on one side of the quarter pair, or neither shares nor value can classify it · "no change" = the share count is identical in both quarters; the value moved only with price, so the row is mark-to-market and never an add or a trim (Add / New / Trim / Exit / No change) · "no prior" = this filer has no comparable holdings list for the previous quarter on record — a first filing under this registration, or a quarter reported inside an affiliated manager's filing — so the position is not called a new stake | Δ valuederived by Public Filings from the published aggregate; NULL means the source did not disclose a usable value — never zero | Δ shares | Prev value | Curr value | Prev shares | Curr shares | Flags |
|---|---|---|---|---|---|---|---|---|
TALEN ENERGY CORP COMposition key pos:16855 · issuer key iss:2082 | no change | −$200M | 0 | $1.4B | $1.1B | 3,602,171 | 3,602,171 | |
GOLAR LNG LTD SHSposition key pos:14289 · issuer key iss:2646 | no change | +$155M | 0 | $342M | $497M | 9,178,978 | 9,178,978 | |
TRANSALTA CORP COMposition key pos:16327 · issuer key iss:2149 | no change | +$8.2M | 0 | $225M | $233M | 17,781,325 | 17,781,325 | |
ARCUTIS BIOTHERAPEUTICS INC COMposition key sid:sec:prov:fa36e00268ee3d6d74f8ff5697fdd99c · issuer key cusip6:03969K | no change | −$45.3M | 0 | $240M | $195M | 8,271,577 | 8,271,577 | |
DELEK US HLDGS INC NEW COMposition key pos:18684 · issuer key iss:718 | no change | +$41.4M | 0 | $79.7M | $121M | 2,687,449 | 2,687,449 | |
ADEIA INC COMposition key pos:18548 · issuer key iss:70 | no change | +$29.0M | 0 | $73.9M | $103M | 4,284,205 | 4,284,205 | |
TELEPHONE & DATA SYS INC COM NEWposition key pos:16493 · issuer key iss:2101 | no change | +$2.0M | 0 | $75.9M | $77.9M | 1,850,000 | 1,850,000 | |
INTEGRA LIFESCIENCES HLDGS C COM NEWposition key sid:sec:prov:07e5c166b1f94f63603a5e11787101d8 · issuer key cusip6:457985 | no change | −$23.3M | 0 | $96.3M | $73.0M | 7,753,934 | 7,753,934 | |
ENOVIS CORPORATION COMposition key pos:13340 · issuer key iss:617 | no change | −$9.5M | 0 | $65.4M | $55.8M | 2,453,265 | 2,453,265 | |
OPKO HEALTH INC COMposition key sid:sec:prov:b6f625b0f073b7046d5aef668a0117ad · issuer key cusip6:68375N | no change | −$5.7M | 0 | $60.2M | $54.5M | 47,791,243 | 47,791,243 | |
RENEW ENERGY GLOBAL PLC CL A SHSposition key pos:12683 · issuer key cusip6:G7500M | no change | −$11.8M | 0 | $62.2M | $50.4M | 11,000,000 | 11,000,000 | |
ORTHOFIX MED INC COMposition key sid:sec:prov:2dd39154b043cf25ad12f54df878e5cb · issuer key cusip6:68752M | no change | −$13.7M | 0 | $56.4M | $42.7M | 3,721,715 | 3,721,715 | |
NURIX THERAPEUTICS INC COMposition key sid:sec:prov:48ac0f50c981e01f7c5af17d58a117cf · issuer key cusip6:67080M | no change | −$8.6M | 0 | $46.9M | $38.3M | 2,473,885 | 2,473,885 | |
MATIV HOLDINGS INC COMposition key sid:sec:prov:15651cc14200588c5866abc5804abfd6 · issuer key cusip6:808541 | no change | −$13.7M | 0 | $48.4M | $34.6M | 3,982,442 | 3,982,442 | |
TELESAT CORP CL A & CL B SHSposition key sid:sec:prov:434935e68a2480e150f61b975b0a747f · issuer key cusip6:879512 | no change | +$6.0M | 0 | $24.6M | $30.5M | 843,781 | 843,781 | |
HERON THERAPEUTICS INC COMposition key sid:sec:prov:bf8ba8a176478fa55a6137c9e08e0ee6 · issuer key cusip6:427746 | no change | −$15.0M | 0 | $39.1M | $24.0M | 30,046,828 | 30,046,828 | |
XPERI INC COMMON STOCKposition key sid:sec:prov:f6dd378480ad01e275a7aee110ed9221 · issuer key cusip6:98423J | no change | −$1.1M | 0 | $24.3M | $23.2M | 4,143,744 | 4,143,744 | |
TARGET HOSPITALITY CORP COMposition key sid:sec:prov:839348e9368272036e4766b0c85320f9 · issuer key cusip6:87615L | no change | +$2.8M | 0 | $17.5M | $20.3M | 2,189,456 | 2,189,456 | |
ACADIA HEALTHCARE COMPANY IN COMposition key pos:13278 · issuer key iss:55 | no change | +$7.8M | 0 | $12.1M | $19.9M | 850,000 | 850,000 | |
SEAPORT ENTMT GROUP INC COMMON STOCKposition key pos:11996 · issuer key iss:1947 | no change | +$972K | 0 | $11.2M | $12.2M | 568,530 | 568,530 | |
CAPRI HOLDINGS LIMITED SHSposition key pos:15998 · issuer key iss:2469 | no change | −$4.6M | 0 | $16.5M | $11.9M | 675,000 | 675,000 | |
EMBECTA CORP COMMON STOCKposition key pos:12610 · issuer key iss:808 | no change | −$3.2M | 0 | $12.3M | $9.2M | 1,037,416 | 1,037,416 | |
MEREO BIOPHARMA GROUP PLC SPON ADSposition key sid:sec:prov:3af9f2163c854ed07645fe0c708030c1 · issuer key cusip6:589492 | no change | −$1.3M | 0 | $6.4M | $5.1M | 15,307,347 | 15,307,347 | |
EDESA BIOTECH INC COM NEWposition key sid:sec:prov:626869004f126eefd6f21e4a4f5ae60f · issuer key cusip6:27966L | no change | +$2.6M | 0 | $976K | $3.6M | 687,500 | 687,500 | |
THERAPEUTICSMD INC COM NEWposition key sid:sec:prov:3019218ff3aaedc49154a828858003b1 · issuer key cusip6:88338N | no change | +$465K | 0 | $1.9M | $2.4M | 1,192,191 | 1,192,191 | |
OPKO HEALTH INC NOTE 3.750% 1/1position key sid:sec:prov:d7787f9f49c22f34871a32ebcd19fdb5 · issuer key cusip6:68375N PRN | no change | −$122K | 0 | $1.7M | $1.5M | 1,250,000 | 1,250,000 | |
PLAYSTUDIOS INC CLASS A COMposition key sid:sec:prov:d9a330858b6d0d176c0ea34dc9e1b07d · issuer key cusip6:72815G | no change | −$492K | 0 | $1.8M | $1.3M | 2,697,384 | 2,697,384 |
Quarter ended 2026-03-31Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.
Changes derive from the aggregate's top-25 slices and keyable positions only; unkeyable holdings are counted in the registry, not differenced. methodology §13F ↗
Book shape
2026-03-31 · concentration · vs tracked median · tick = median- Top-25 concentration
- 78.9%below median 80.0%
- Concentration index
- 518 bpsabove median 446 bps
- Positions with value
- 83 / 83median book 97.5 positions
Concentration uses reported 13F long value, not total assets. The index is withheld when any position lacks a value. Medians are over the 8,748 tracked filers with a 2026-03-31 book; the index median over the 8,662 with a complete book.
null-value positions: 0holdings whose <value> did not parse — retained and counted, never zero-filled · top-N share ·§: 78.9% · HHI (bps) ·§: 518integer Herfindahl–Hirschman index in basis points over disclosed position values · QoQ moves: 93
Filing history
AVAILABLE QUARTERS| Period | Source |
|---|---|
| 2026-03-31 | EDGAR ↗ |
PLANNED sector rotation · Congress overlap · signals for this filer
Complete source filings on SEC EDGAR
The complete filing on EDGAR.
The position list above is served from the published Public Filings build — every position this filer reported for the selected quarter, as it reported it. This block is provenance, not a substitute: the filing itself is the record, and it is one click away. Serving this list is M2-CONTRACT §3, amended 2026-08-02; §3.1 keeps live EDGAR for filings newer than this build.
Open Rubric Capital Management LP's 13F filings on SEC EDGAR ↗Notes on this data
Share changes
Compare consecutive quarters
Position changes retain the producer’s classification and comparability flags. Share counts and reported values describe different changes.
Coverage
A snapshot, not current holdings
Use the quarter selector to inspect available periods. Unknown values stay unknown and each table states its coverage.
ViewPrior quarter not yet availableThis build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.
Reported positions — 2026-03-31
1–80 of 80 issuers · $9.4B disclosed value over 83 rows · 0 undisclosed-value rowsEvery row below carries ticker not yet mapped — stated once here rather than repeated on every row.
| KindClassification is not joined into this reported-position view. Use the changed-positions view to compare the two published quarters. | TickerThis list carries reported issuer names and security identities, without a dated ticker mapping. Symbols are not inferred from names. | Issuera position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filing | WeightShare of total reported value, calculated only when the full position list has disclosed values. This is 13F long value, not total assets. | Valuevalue undisclosed on the filing: retained and counted, excluded from sums, never shown as $0 | Shares | Position changeShare change is available in the separate comparison view; it is not joined into this position list. | Wt | CongressThe congressional transaction join is unavailable in this build. |
|---|---|---|---|---|---|---|---|---|
| — | — | ISHARES TR ISHARES TR · RUSSELL 2000 ETF · PUT CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $1.3B | 5,150,000 | — | 13.5% | — | |
| — | TLNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TALEN ENERGY CORP TALEN ENERGY CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $1.1B | 3,602,171 | — | 12.2% | — | |
| — | FTAIverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | FTAI AVIATION LTD FTAI AVIATION LTD · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $631M | 2,576,186 | — | 6.7% | — | |
| — | GLNGverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GOLAR LNG LTD GOLAR LNG LTD · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $497M | 9,178,978 | — | 5.3% | — | |
| — | TEVAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TEVA PHARMACEUTICAL INDS LTD TEVA PHARMACEUTICAL INDS LTD · SPONSORED ADS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $459M | 15,250,000 | — | 4.9% | — | |
| — | VTRSverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VIATRIS INC VIATRIS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $453M | 33,500,000 | — | 4.8% | — | |
| — | LBTYKverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | LIBERTY GLOBAL LTD | $251M | 21,012,216 | — | 2.7% | — | |
| — | TACverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TRANSALTA CORP TRANSALTA CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $233M | 17,781,325 | — | 2.5% | — | |
| — | BGCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BGC GROUP INC BGC GROUP INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $228M | 23,300,000 | — | 2.4% | — | |
| — | VSTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VISTRA CORP VISTRA CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $225M | 1,500,000 | — | 2.4% | — | |
| — | CEGverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CONSTELLATION ENERGY CORP CONSTELLATION ENERGY CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $200M | 715,000 | — | 2.1% | — | |
| — | — | ARCUTIS BIOTHERAPEUTICS INC ARCUTIS BIOTHERAPEUTICS INC · COM CUSIP 03969K108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $195M | 8,271,577 | — | 2.1% | — | |
| — | MCYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MERCURY GENL CORP NEW MERCURY GENL CORP NEW · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $190M | 2,154,504 | — | 2.0% | — | |
| — | KNSAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | KINIKSA PHARMACEUTICALS INTL KINIKSA PHARMACEUTICALS INTL · ORD SHS CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $181M | 3,750,000 | — | 1.9% | — | |
| — | — | ZYMEWORKS INC ZYMEWORKS INC · COM CUSIP 98985Y108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $175M | 7,000,000 | — | 1.9% | — | |
| — | — | LIBERTY LATIN AMERICA LTD | $168M | 19,145,430 | — | 1.8% | — | |
| — | AKAMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | AKAMAI TECHNOLOGIES INC AKAMAI TECHNOLOGIES INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $149M | 1,300,000 | — | 1.6% | — | |
| — | ROIVverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ROIVANT SCIENCES LTD ROIVANT SCIENCES LTD · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $139M | 5,000,000 | — | 1.5% | — | |
| — | AMRXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | AMNEAL PHARMACEUTICALS INC AMNEAL PHARMACEUTICALS INC · COM STK CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $137M | 11,037,589 | — | 1.5% | — | |
| — | DKverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DELEK US HLDGS INC NEW DELEK US HLDGS INC NEW · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $121M | 2,687,449 | — | 1.3% | — | |
| — | — | CIMPRESS PLC CIMPRESS PLC · SHS EURO CUSIP G2143T103 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $119M | 1,629,419 | — | 1.3% | — | |
| — | ECVTverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ECOVYST INC ECOVYST INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $117M | 9,136,067 | — | 1.2% | — | |
| — | ADEAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ADEIA INC ADEIA INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $103M | 4,284,205 | — | 1.1% | — | |
| — | — | EDGEWELL PERSONAL CARE CO EDGEWELL PERSONAL CARE CO · COM CUSIP 28035Q102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $85.4M | 4,000,000 | — | 0.9% | — | |
| — | ZMverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ZOOM COMMUNICATIONS INC ZOOM COMMUNICATIONS INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $80.5M | 1,001,006 | — | 0.9% | — | |
| — | TDSverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TELEPHONE & DATA SYS INC TELEPHONE & DATA SYS INC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $77.9M | 1,850,000 | — | 0.8% | — | |
| — | GILverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GILDAN ACTIVEWEAR INC GILDAN ACTIVEWEAR INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $77.7M | 1,395,790 | — | 0.8% | — | |
| — | — | INTEGRA LIFESCIENCES HLDGS C INTEGRA LIFESCIENCES HLDGS C · COM NEW CUSIP 457985208 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $73.0M | 7,753,934 | — | 0.8% | — | |
| — | SDGRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SCHRODINGER INC SCHRODINGER INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $68.2M | 6,000,000 | — | 0.7% | — | |
| — | SPRYverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ARS PHARMACEUTICALS INC ARS PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $64.2M | 8,000,000 | — | 0.7% | — | |
| — | GEOverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | GEO GROUP INC GEO GROUP INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $62.9M | 3,743,180 | — | 0.7% | — | |
| — | — | STRATASYS LTD STRATASYS LTD · SHS CUSIP M85548101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $62.5M | 8,000,000 | — | 0.7% | — | |
| — | ANDEverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ANDERSONS INC ANDERSONS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $61.4M | 855,819 | — | 0.7% | — | |
| — | — | MEIRAGTX HLDGS PLC MEIRAGTX HLDGS PLC · COM CUSIP G59665102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $60.6M | 7,000,000 | — | 0.6% | — | |
| — | — | OPKO HEALTH INC | $56.0M | — | — | 0.6% | — | |
| — | ENOVverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ENOVIS CORPORATION ENOVIS CORPORATION · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $55.8M | 2,453,265 | — | 0.6% | — | |
| — | — | QUIDELORTHO CORP QUIDELORTHO CORP · COM CUSIP 219798105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $54.3M | 3,306,281 | — | 0.6% | — | |
| — | PRMBverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PRIMO BRANDS CORPORATION PRIMO BRANDS CORPORATION · CLASS A COM SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $52.4M | 2,782,404 | — | 0.6% | — | |
| — | NWLverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | NEWELL BRANDS INC NEWELL BRANDS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $52.3M | 15,257,431 | — | 0.6% | — | |
| — | AMCRverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | AMCOR PLC AMCOR PLC · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $50.5M | 1,269,396 | — | 0.5% | — | |
| — | — | RENEW ENERGY GLOBAL PLC RENEW ENERGY GLOBAL PLC · CL A SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $50.4M | 11,000,000 | — | 0.5% | — | |
| — | — | PROTHENA CORP PLC PROTHENA CORP PLC · SHS CUSIP G72800108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $48.6M | 5,000,000 | — | 0.5% | — | |
| — | PTGXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PROTAGONIST THERAPEUTICS INC PROTAGONIST THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $45.1M | 427,998 | — | 0.5% | — | |
| — | TRVIverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | TREVI THERAPEUTICS INC TREVI THERAPEUTICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $44.3M | 3,712,373 | — | 0.5% | — | |
| — | — | ORTHOFIX MED INC ORTHOFIX MED INC · COM CUSIP 68752M108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $42.7M | 3,721,715 | — | 0.5% | — | |
| — | COLLverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | COLLEGIUM PHARMACEUTICAL INC COLLEGIUM PHARMACEUTICAL INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $42.3M | 1,279,611 | — | 0.4% | — | |
| — | CXWverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CORECIVIC INC CORECIVIC INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $38.9M | 2,059,216 | — | 0.4% | — | |
| — | — | NURIX THERAPEUTICS INC NURIX THERAPEUTICS INC · COM CUSIP 67080M103 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $38.3M | 2,473,885 | — | 0.4% | — | |
| — | DRVNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DRIVEN BRANDS HLDGS INC DRIVEN BRANDS HLDGS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $37.8M | 3,000,000 | — | 0.4% | — | |
| — | — | CALAVO GROWERS INC CALAVO GROWERS INC · COM CUSIP 128246105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $36.5M | 1,416,662 | — | 0.4% | — | |
| — | CRIverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CARTERS INC CARTERS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $36.4M | 1,018,853 | — | 0.4% | — | |
| — | VISNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VISTANCE NETWORKS INC VISTANCE NETWORKS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $36.4M | 2,000,000 | — | 0.4% | — | |
| — | — | MATIV HOLDINGS INC MATIV HOLDINGS INC · COM CUSIP 808541106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $34.6M | 3,982,442 | — | 0.4% | — | |
| — | — | TELESAT CORP TELESAT CORP · CL A & CL B SHS CUSIP 879512309 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $30.5M | 843,781 | — | 0.3% | — | |
| — | ABUSverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ARBUTUS BIOPHARMA CORP ARBUTUS BIOPHARMA CORP · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $29.8M | 6,626,389 | — | 0.3% | — | |
| — | PRLBverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | PROTO LABS INC PROTO LABS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $27.7M | 486,400 | — | 0.3% | — | |
| — | COMPverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | COMPASS INC COMPASS INC · CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $27.4M | 3,746,848 | — | 0.3% | — | |
| — | BMRNverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | BIOMARIN PHARMACEUTICAL INC BIOMARIN PHARMACEUTICAL INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $24.9M | 440,560 | — | 0.3% | — | |
| — | — | HERON THERAPEUTICS INC HERON THERAPEUTICS INC · COM CUSIP 427746102 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $24.0M | 30,046,828 | — | 0.3% | — | |
| — | AVOverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | MISSION PRODUCE INC MISSION PRODUCE INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $23.8M | 1,726,447 | — | 0.3% | — | |
| — | VGverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | VENTURE GLOBAL INC VENTURE GLOBAL INC · COM CL A CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $23.6M | 1,500,000 | — | 0.3% | — | |
| — | — | XPERI INC XPERI INC · COMMON STOCK CUSIP 98423J101 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $23.2M | 4,143,744 | — | 0.2% | — | |
| — | — | TARGET HOSPITALITY CORP TARGET HOSPITALITY CORP · COM CUSIP 87615L107 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $20.3M | 2,189,456 | — | 0.2% | — | |
| — | INDVverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | INDIVIOR PHARMACEUTICALS INC INDIVIOR PHARMACEUTICALS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $20.2M | 662,515 | — | 0.2% | — | |
| — | ACHCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ACADIA HEALTHCARE COMPANY IN ACADIA HEALTHCARE COMPANY IN · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $19.9M | 850,000 | — | 0.2% | — | |
| — | ADMAverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ADMA BIOLOGICS INC ADMA BIOLOGICS INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $16.3M | 1,809,408 | — | 0.2% | — | |
| — | DNOWverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | DNOW INC DNOW INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $15.1M | 1,267,527 | — | 0.2% | — | |
| — | SEGverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | SEAPORT ENTMT GROUP INC SEAPORT ENTMT GROUP INC · COMMON STOCK CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $12.2M | 568,530 | — | 0.1% | — | |
| — | CPRIverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | CAPRI HOLDINGS LIMITED CAPRI HOLDINGS LIMITED · SHS CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $11.9M | 675,000 | — | 0.1% | — | |
| — | ARDXverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | ARDELYX INC ARDELYX INC · COM CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $11.1M | 1,860,896 | — | 0.1% | — | |
| — | EMBCverified against the SEC company list on 2026-09-10 — a reviewed mapping row for this filed issuer name and class (never inferred) | EMBECTA CORP EMBECTA CORP · COMMON STOCK CUSIP — quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $9.2M | 1,037,416 | — | 0.1% | — | |
| — | — | MANNKIND CORP MANNKIND CORP · COM NEW CUSIP 56400P706 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $8.9M | 3,620,413 | — | 0.1% | — | |
| — | — | GRUPO AEROMEXICO SAB DE CV GRUPO AEROMEXICO SAB DE CV · SPONSORED ADS CUSIP 40054J109 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $6.5M | 467,129 | — | 0.1% | — | |
| — | — | HELEN OF TROY LTD HELEN OF TROY LTD · COM CUSIP G4388N106 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $5.3M | 366,226 | — | 0.1% | — | |
| — | — | MEREO BIOPHARMA GROUP PLC MEREO BIOPHARMA GROUP PLC · SPON ADS CUSIP 589492107 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $5.1M | 15,307,347 | — | 0.1% | — | |
| — | — | EUPRAXIA PHARMACEUTICALS INC EUPRAXIA PHARMACEUTICALS INC · COM CUSIP 29842P105 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $5.0M | 691,170 | — | 0.1% | — | |
| — | — | PENNYMAC FINL SVCS INC NEW PENNYMAC FINL SVCS INC NEW · COM CUSIP 70932M107 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $4.8M | 54,727 | — | 0.1% | — | |
| — | — | EDESA BIOTECH INC EDESA BIOTECH INC · COM NEW CUSIP 27966L306 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $3.6M | 687,500 | — | 0.0% | — | |
| — | — | THERAPEUTICSMD INC THERAPEUTICSMD INC · COM NEW CUSIP 88338N206 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $2.4M | 1,192,191 | — | 0.0% | — | |
| — | — | PLAYSTUDIOS INC PLAYSTUDIOS INC · CLASS A COM CUSIP 72815G108 quarter ended 2026-03-31 filed filed 2026-05-15 +45d | $1.3M | 2,697,384 | — | 0.0% | — |
1–80 of 80 issuers · page 1 of 1
every row this filer reported for the quarter, as it reported it — cross-filer de-duplication is applied to issuer totals elsewhere and never deletes a row here
A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗
13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.
Positions are quarter-end snapshots filed up to 45 days late — not current holdings. A position may have been changed or closed before you ever see it, and is older still by however long ago that quarter ended.
Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars with unit_basis carried on every record.
Affiliated managers may report the same position (otherManager), so one position can appear under more than one filer.
Positions under confidential treatment may be omitted until a later amendment discloses them.
These are disclosures, not investment advice (ARCHITECTURE.md §5.2 / M2-CONTRACT §5).